Formulation Development of a pH-Adjusted, Preservative-Free 1% 5-Fluorouracil Eye Drop Compounded from…

Formulation and Stability Screening of Walnut Protein Concentrate-Whey Protein Isolate Stabilized Pickering Emulsions with Different Compounding Ratios: Capsanthin Loading, Multi-Condition Stability, and Application as a Butter Replacer in Spreadable Products.
Mihreban Sawaidul, Jiarui Li, Mingqiang Xu +4
Foods (Basel, Switzerland)25 Sep 2026Peer-reviewedCC BYFull textEurope PMC
Deep learning and metaheuristic optimization for predicting drug release from nanocarrier systems: a data-driven framework for formulation development
Hadil Faris Alotaibi, Saad S. Alqahtani
Frontiers in medicine19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Quality by Design (QbD) Empowered by IVIVR Modelling: A Predictive Approach for Drug Formulation Development
Dr Mohamed Baraadid, Nadia Ibntabet, Karim Lahlou
International Journal of Pharmaceutical Sciences Review and Research4 Nov 2026Peer-reviewedLicence not statedFull textPharmacology & toxicologyHAL
Applicability of a miniaturized precipitation assay as an early-stage screening tool for prototype formulation development
Sara Mayer, Katharina Krollik, Christian Wagner +3
International journal of pharmaceutics: X1 Oct 2026Peer-reviewedCC BYFull textEurope PMC
Formulation Development and Characterization of Quercetin Solid Dispersions with Integrated In Vitro Release and In Vivo Pharmacokinetic Assessment
Zi-Xuan Guo, Zi-Yang Li, Xia-Li Wei +4
Pharmaceuticals (Basel, Switzerland)1 Oct 2026Peer-reviewedCC BYFull textEurope PMC

Cite

BibTeX

@article{anon2026formulation,
  title = {{Formulation Development of a pH-Adjusted, Preservative-Free 1% 5-Fluorouracil Eye Drop Compounded from Injectable Concentrate: A Risk-Assessed Magistral Formulation and 28-Day Stability Case Study}},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13708713},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Formulation Development of a pH-Adjusted, Preservative-Free 1% 5-Fluorouracil Eye Drop Compounded from Injectable Concentrate: A Risk-Assessed Magistral Formulation and 28-Day Stability Case Study
PY  - 2026
DA  - 2026/10/01
JO  - Pharmaceuticals (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13708713
SN  - 1424-8247
ER  -

Related

Cite